Daniel Gaudet

Dr. Daniel Gaudet is an Associate Professor at the University of Montréal's Faculty of Medicine, Department of Medicine. He specializes in preventive genetics, community genomics, and predictive medicine, particularly focusing on cardiovascular genetic determinants and familial dyslipoproteinemias. His research emphasizes genotype-phenotype associations in lipid metabolism disorders.

He has supervised numerous Master's theses on topics like familial hypercholesterolemia, acute pancreatitis, and lipid disorder genetics. His research has been funded by the Canadian Institutes of Health Research (CIHR) for initiatives like the ECOGENE-21 Team in Community Genetics and projects addressing familial hypercholesterolemia and prenatal smoking impacts on brain development.

Key collaborations include work with institutions like the Regroupement droit, changements et gouvernance. His studies often involve multidisciplinary teams and focus on translational research bridging genetics, public health, and clinical practice. Notable projects include long-term outcomes of HoFH patients and biobanking infrastructure designed for community health needs.

Dr. Gaudet has contributed to guidelines on chylomicronemia management and lipid-lowering therapies. His work emphasizes equitable access to precision medicine for rare lipid disorders through programs like SMASH. He has authored over 150 peer-reviewed articles on genetic lipid disorders, RNAi therapeutics, and cardiovascular genetics.